2Jacobsen DW, Gatautis VJ, Green R, et al. Rapid HPLC determination of total homocysteine and other thiols in serum and plasma: Sex differences and correlation with cobalamin and folate concentrations in healthy subjects. Clin Chem, 1994, 40:873-881.
4Yeun JY. The role of homocysteine in end - stage renal disease.Seminars in Dialysis, 1998, 11: 95-101.
5Nygard O, Norderhaug JE, Refsum H, et al. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med, 1997, 337: 230-236.
6Bostom AG, Lathrop L. Hyperhomocysteinemia in end- stage renal disease: prevalence, etiology, and potential relationship to artherosclerotic outcomes. Kidney Int, 1997, 52: 10-20.
7Foley RN, Parfrey PS, Samak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis,1998,32 Suppl 3: 112-119.
8Yu HH, Joubran R, Asmi M, et al. Agreement among four homocysteine assays and results in patients with coronaryatherosclerosis and controls. Clin Chem, 2000, 46: 258-264.
9Hultberg B, Andersson A, Arnadottir M. Reduced, free and total fractions of homocysteine and other thiol compounds in plasma from patients with renal failure. Nephron, 1995, 70: 62-67.
10Bostom AG, Culleton BF. Hyperhomocysteinemia in chronic renal disease. J Am Soc Nephron, 1999, 10: 891-900.
